Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rowan T Chlebowski

Showing results (91-100 of 366) with videos related to

Pageof 37
Sort By:
Clinical Trials (London, England)|September 14, 2010
Prospective evaluation of two recruitment strategies for a randomized controlled cancer prevention trialRowan T Chlebowski, Rashmi Menon, Roslyn M Chaisanguanthum, et al.
Journal of the National Cancer Institute|November 8, 2015
Breast Cancer and Menopausal Hormone Therapy by Race/Ethnicity and Body Mass IndexRowan T Chlebowski, Garnet L Anderson, Aaron K Aragaki, et al.
Breast Cancer Research and Treatment|January 20, 2019
Aromatase inhibitor and tamoxifen use and the risk of venous thromboembolism in breast cancer survivorsXiaoqing Xu, Rowan T Chlebowski, Jiaxiao Shi, et al.
Cancer|March 27, 2020
Forty-year trends in menopausal hormone therapy use and breast cancer incidence among postmenopausal black and white womenRowan T Chlebowski, Aaron K Aragaki, Garnet L Anderson, et al.
Ethnicity & Disease|November 9, 2018
Breast Cancer Outcomes in a Racially and Ethnically Diverse Cohort of Insured WomenReina Haque, Xiaoqing Xu, Jiaxiao Shi, et al.
Cancer|March 12, 2015
Aromatase inhibitors, tamoxifen, and endometrial cancer in breast cancer survivorsRowan T Chlebowski, Joanne E Schottinger, Jiaxiao Shi, et al.
Breast Cancer (Dove Medical Press)|August 22, 2023
Risk of Subsequent Breast Cancer in Women with Early Stage HER2-Positive Breast Cancer in a Large Community Health PlanReina Haque, Lie Hong Chen, Nina Oestreicher, et al.
Cancer|January 20, 2011
Comorbidities and mammography use interact to explain racial/ethnic disparities in breast cancer stage at diagnosisShagufta Yasmeen, Guibo Xing, Cyllene Morris, et al.
Cancer|November 10, 2020
Reply to The Women's Health Initiative; hormone replacement therapy; and Surveillance, Epidemiology, and End Results dataRowan T Chlebowski, Aaron K Aragaki, Garnet L Anderson, et al.
Annals of Surgical Oncology|July 30, 2020
Single Hormone Receptor-Positive Breast Cancers Have Distinct Characteristics and SurvivalChristine Dauphine, Ashkan Moazzez, Jasmin C Neal, et al.
Pageof 37

Showing results (91-100 of 366) with videos related to

Sort By:
Pageof 37
Clinical Trials (London, England)|September 14, 2010
Prospective evaluation of two recruitment strategies for a randomized controlled cancer prevention trialRowan T Chlebowski, Rashmi Menon, Roslyn M Chaisanguanthum, et al.
Journal of the National Cancer Institute|November 8, 2015
Breast Cancer and Menopausal Hormone Therapy by Race/Ethnicity and Body Mass IndexRowan T Chlebowski, Garnet L Anderson, Aaron K Aragaki, et al.
Breast Cancer Research and Treatment|January 20, 2019
Aromatase inhibitor and tamoxifen use and the risk of venous thromboembolism in breast cancer survivorsXiaoqing Xu, Rowan T Chlebowski, Jiaxiao Shi, et al.
Cancer|March 27, 2020
Forty-year trends in menopausal hormone therapy use and breast cancer incidence among postmenopausal black and white womenRowan T Chlebowski, Aaron K Aragaki, Garnet L Anderson, et al.
Ethnicity & Disease|November 9, 2018
Breast Cancer Outcomes in a Racially and Ethnically Diverse Cohort of Insured WomenReina Haque, Xiaoqing Xu, Jiaxiao Shi, et al.
Cancer|March 12, 2015
Aromatase inhibitors, tamoxifen, and endometrial cancer in breast cancer survivorsRowan T Chlebowski, Joanne E Schottinger, Jiaxiao Shi, et al.
Breast Cancer (Dove Medical Press)|August 22, 2023
Risk of Subsequent Breast Cancer in Women with Early Stage HER2-Positive Breast Cancer in a Large Community Health PlanReina Haque, Lie Hong Chen, Nina Oestreicher, et al.
Cancer|January 20, 2011
Comorbidities and mammography use interact to explain racial/ethnic disparities in breast cancer stage at diagnosisShagufta Yasmeen, Guibo Xing, Cyllene Morris, et al.
Cancer|November 10, 2020
Reply to The Women's Health Initiative; hormone replacement therapy; and Surveillance, Epidemiology, and End Results dataRowan T Chlebowski, Aaron K Aragaki, Garnet L Anderson, et al.
Annals of Surgical Oncology|July 30, 2020
Single Hormone Receptor-Positive Breast Cancers Have Distinct Characteristics and SurvivalChristine Dauphine, Ashkan Moazzez, Jasmin C Neal, et al.
Pageof 37